Latest Breaking News On - Markus manns - Page 2 : comparemela.com

Health: Blockbuster obesity drug demand drives Novo Nordisk profit boost

Novo Nordisk raises outlook fuelled by obesity drug demand By Reuters

Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drug

Novo Nordisk reported better-than-expected first-quarter profits on Thursday as it looks to fend off competition from rival Eli Lilly

Bayer investors weigh need for cash call amid stifling debt

Bayer may have to ask shareholders for fresh capital to shore up its finances even after the debt-laden German drugmaker slashed dividends last week in its latest effort to get wiggle room,.

Analysis-Bayer investors weigh need for cash call amid stifling debt

Bayer may have to ask shareholders for fresh capital to shore up its finances even after the debt-laden German drugmaker slashed dividends last week in its latest effort to get wiggle room, analysts said. But new CEO Bill Anderson may struggle to win over investors, who have seen the company's value sink by two thirds since its $63 billion acquisition of Monsanto in 2018, which saddled it with costly litigation and debt. The debate over a possible share issue comes as Anderson, who was hired last June to revive the company's fortunes, prepares to deliver a strategic investor update in London on Tuesday.